Circio
Pre-clinicalCircio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Founded
2014
Focus
BiologicsViral Technology
About
Circio Holding ASA (OSE:TRVX, to be changed to CRNA), a biotechnology company developing novel circular RNA and immunotherapy medicines.
Funding History
2Total raised: $37M
Series B$25MUndisclosedOct 15, 2021
Series A$12MSarsia SeedMay 15, 2019
Company Info
TypePrivate
Founded2014
LocationOslo, Norway
StagePre-clinical
Contact
SIMILAR COMPANIES
Algipharma
Phase 1 · Bergen
Bio-Me
Pre-clinical · Oslo
CardiNor
Pre-clinical · Oslo
Gentian USA
Pre-clinical · Moss
Hemispherian
Phase 1 · Oslo
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile